Event Brief
Dec 18, 2025 at 7:03 AM ET
Eli Lilly's Obesity Pill Shows Weight Loss Maintenance
By The BriefBrief
Eli Lilly reports its obesity pill, orforglipron, helps maintain weight loss after switching from Wegovy and Zepbound.
WHO: Eli Lilly
WHAT: Obesity pill orforglipron helps maintain weight loss
WHEN: Dec 17, 2025 at 7:00 PM ET
WHERE: United States
WHY: To seek FDA approval for a new obesity treatment
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21434 of 21434
Same format. Every time.
Continue reading — sign in or create a free account with
